An international provider of integrated state of the art Laboratory Services and Products. Headquartered in Nottingham, UK with locations in Cambridge, Rochdale, Ireland and San Diego, USA.
We are ISO15189, GCP and GMP accredited, ISO9001:2008 certified licensed by the Human Tissue Authority and registered with the Care Quality Commission.
Serving a variety of markets, our multidisciplinary expertise includes:
- Cellular and digital pathology
- Molecular diagnostics
- Genomics laboratory services
- Stability storage solutions
For Media or Investor queries please email [email protected]
|
|
|
51-200 employees
View all Source BioScience employees
|
|
Biotechnology
|
|
1 Orchard Place, Nottingham Business Park, Nottingham, Nottinghamshire NG8 6PX, GB
|
|
Life Sciences, Pharmaceuticals, Clinical Trials, Dna Sequencing, Diagnostics, Drug Development, Bioinformatics, Digital Pathology, Histopathology, Antibodies, Next Generation Sequencing, Genotyping, Genomics, Stability Storage, Healthcare Services, Diagnostic Testing, Gene Expression, Laboratory Services, Genomic Services, Cellular Pathology
|
Jay Lecoque is the CEO of Source BioScience. To contact Jay Lecoque email at [email protected] or [email protected].
The decision makers in Source BioScience are Ian Ellis, Jackie Rodgers, Jackie Rodgers, etc. Click to Find Source BioScience decision makers emails.
Source BioScience offers a comprehensive range of laboratory services, including DNA sequencing, genomic services, histopathology, digital pathology, and diagnostic testing. Our services cater to various sectors, including life sciences, pharmaceuticals, and healthcare, ensuring that we meet the diverse needs of our clients.
Source BioScience supports clinical trials by providing essential laboratory services such as sample analysis, biomarker testing, and data management. Our expertise in bioinformatics and genomic services ensures that we deliver accurate and timely results, which are crucial for the success of clinical trials and drug development.
Source BioScience serves a wide range of industries, including life sciences, pharmaceuticals, healthcare, and biotechnology. Our integrated laboratory services and products are designed to support research and development, diagnostics, and drug development across these sectors.
Next Generation Sequencing (NGS) is a high-throughput method used to sequence DNA and RNA, allowing for comprehensive genomic analysis. Source BioScience utilizes NGS in various applications, including genomic research, clinical diagnostics, and personalized medicine, providing clients with detailed insights into genetic information.
Yes, Source BioScience offers stability storage services for pharmaceutical products. Our facilities are equipped to maintain the necessary environmental conditions for the long-term storage of samples, ensuring compliance with regulatory requirements and supporting the stability testing of drug products.
Source BioScience is ISO 15189 accredited, which demonstrates our commitment to quality and competence in medical laboratories. This certification ensures that our laboratory services meet international standards for quality management and technical competence, providing clients with confidence in our testing and analysis.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.